The phosphatidyl-inositol-3-kinase/serine/threonine kinase AKT (PI3K/AKT) signaling pathway is hyper-activated in many human cancers, including glioblastoma, thyroid cancer and ESCC [14, 30, 31]. The gene discussed is MARK2; the disease is thyroid cancer.